According to the report titled ‘Global Neurovascular Devices Market Analysis, Size, Share, Segmentation and Competitive Landscape (2013 - 2017) and Future Forecast (2018 - 2025),’ available with MarketStudyReport, global neurovascular devices market is expected to amass a valuation of USD 5 billion during the period 2018-2025.
 

Rise in the proportion of obese as well as aging population, increasing patient pool for ischemic & hemorrhagic stroke, and massive investments in the healthcare infrastructure are factors propelling the growth of global neurovascular devices market.
 

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/1247173/
 

Moreover, ongoing product commercialization & development is further accelerating industry progress. Besides this, technological advancements in the neurovascular field, and surging preference for minimally invasive surgeries are anticipated to create lucrative opportunities for businesses in this line of work in the forthcoming years.
 

Apart from highlighting the driver, the report also enumerated the restraints & challenges in this business sphere. A comparative study of historic data and present trends is conducted to predict the growth rate and renumeration scope of the industry over 2018-2025.
 

Based on product terrain, worldwide neurovascular devices market is classified into micro wire/catheter, flow diverter stent, coil assist stent, coil assist balloon, liquid embolic, clot removal, carotid stent, coil, and others.
 

Speaking of application scope, the industry is divided into arteriovenous malformation (AVM), ischemic stroke, intracranial atherosclerotic disease (ICAD), aneurysm, and others.
 

Moving on to geographical aspect, the study identifies industry trends across nations like United States, Canada, France, Spain, Germany, Italy, United Kingdom, India, Japan, China, and Brazil.
 

The competitive landscape of global neurovascular devices market is discussed in the document by enlisting companies such as Integer Holdings Corporation, Stryker Corporation, Cerenovus (Johnson & Johnson), Medtronic plc, MicroPort Scientific Corporation, MicroVention Inc. (Terumo Corporation), and Penumbra Inc. among others. These prominent players are assessed on numerous parameters such as product portfolios, recent developments in the form of mergers & acquisitions, new product launches, partnerships, etc., and market stake.